Synergy CHC (SNYR) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
26 Dec, 2025Executive summary
Achieved eighth consecutive profitable quarter and full-year profitability for 2024, demonstrating ongoing business strength despite revenue and net income declines year-over-year.
Completed NASDAQ listing/IPO in October 2024, raising over $6.2 million in net proceeds and began trading as SNYR.
Finalized rebranding of Focus Factor/FOCUSfactor, first since 2015.
Expanded retail distribution to 267 BJ's Wholesale Clubs and 1,200 Publix supermarkets.
Appointed Jaime Fickett as permanent CFO.
Financial highlights
Q4 2024 net revenue was $10.3M, down 22% year-over-year; excluding a one-time $875K return, revenue would have been $11.2M.
Q4 2024 gross margin was 63.3% (vs. 82.3% prior year, which included a $2.2M one-time gain); full-year gross margin was 67.9% (vs. 75%).
Q4 2024 net income was $105,700 ($0.01/share), down from $2.6M ($0.35/share) prior year; full-year net income was $2.1M ($0.28/share), down from $6.3M ($0.86/share).
Adjusted EBITDA for Q4 2024 was $2.8M, up 1,033% year-over-year; full-year adjusted EBITDA was $7.4M, up 21%.
Q4 2024 EBITDA was $1.7M (down from $4.5M); full-year EBITDA was $6.5M (down from $10.8M).
Outlook and guidance
Expecting return to top-line and bottom-line growth in 2025 as retailer de-inventorying and packaging transition are complete.
Launched seven new Flat Tummy products in Q1 2025 targeting GLP-1 support.
Expanding RTD beverage distribution and entering three new international markets in 2025.
Management expresses confidence in long-term value creation and growth opportunities.
Latest events from Synergy CHC
- Q3 sales fell on rebranding, but profitability, liquidity, and growth plans remain strong.SNYR
Q3 202411 Jan 2026 - All director nominees and key proposals were approved, with results to be filed with the SEC.SNYR
AGM 20256 Jan 2026 - Shelf registration for $100M in securities, with $5.69M ATM offering to fund growth and expansion.SNYR
Registration Filing16 Dec 2025 - Annual meeting to vote on directors, auditor, equity plan, and preferred stock authorization.SNYR
Proxy Filing2 Dec 2025 - Stockholders to vote on director elections, auditor, equity plan, and preferred stock authorization.SNYR
Proxy Filing2 Dec 2025 - Shareholders will vote on directors, auditor, equity plan expansion, and preferred stock authorization.SNYR
Proxy Filing2 Dec 2025 - Health and wellness firm targets Nasdaq IPO to fund growth amid strong 2023 results and high debt.SNYR
Registration Filing30 Nov 2025 - Consumer health company targets Nasdaq IPO to fund growth amid high debt and concentrated sales.SNYR
Registration Filing30 Nov 2025 - IPO aims to fund brand growth and expansion amid recent financial improvement and high leverage.SNYR
Registration Filing30 Nov 2025